04:27 PM EST, 03/06/2024 (MT Newswires) -- Christopher Mutz, Head of Rare Diseases, on March 05, 2024, sold 5,000 shares in Ani Pharmaceuticals ( ANIP ) for $330,000. Following the Form 4 filing with the SEC, Mutz has control over a total of 87,387 shares of the company, with 87,387 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1023024/000184648724000008/xslF345X03/wk-form4_1709760262.xml